Stock Events

Stock Events

Aqua Bio Technology ASA 

kr5.10
4563
+kr0.00+0% Wednesday 07:31

Statistics

Day High
5.12
Day Low
5.1
52W High
5.12
52W Low
4.65
Volume
415
Avg. Volume
1,900
Mkt Cap
8.82B
P/E Ratio
-
Dividend Yield
454.23%
Dividend
23.17

Upcoming

Dividends

454.23%Dividend Yield
Aug 26
kr5.93
May 26
kr5.86
Feb 26
kr5.99
Nov 25
kr5.96
Aug 25
kr6.01
10Y Growth
9.29%
5Y Growth
7.72%
3Y Growth
7.43%
1Y Growth
6.9%

Earnings

21OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
1.07
1.21
1.36
1.5
Expected EPS
1.419403
Actual EPS
N/A

Financials

14.7%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
449.63BRevenue
66.08BNet Income

Analyst Ratings

721.60Average Price Target
The highest estimate is 836.93.
From 17 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0I8C.LSE. It's not an investment recommendation.
Apple
1096
AAPL
Microsoft
1094
MSFT
Johnson & Johnson
934
JNJ
Coca-Cola
928
KO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson competes with Abbott in multiple segments including medical devices, diagnostics, and pharmaceuticals, making it a direct competitor across several of Abbott's business lines.
Medtronic
MDT
Mkt Cap120.46B
Medtronic competes with Abbott in the medical devices sector, particularly in cardiovascular and diabetes care products.
Thermo Fisher Scientific
TMO
Mkt Cap226.94B
Thermo Fisher Scientific competes with Abbott in the diagnostics and life sciences sector, offering a range of analytical instruments, reagents, and consumables.
Danaher
DHR
Mkt Cap145.98B
Danaher Corporation competes with Abbott in the diagnostics and life sciences industry, particularly through its subsidiary Cepheid, which offers molecular diagnostics solutions.
Boston Scientific
BSX
Mkt Cap69.27B
Boston Scientific competes with Abbott in the medical devices sector, especially in cardiovascular products.
Baxter International
BAX
Mkt Cap13.35B
Baxter International competes with Abbott in the medical devices and nutrition sectors, offering products for critical care, nutrition, renal care, and more.
Stryker
SYK
Mkt Cap116.27B
Stryker competes with Abbott in the medical devices sector, particularly in orthopedics, which indirectly competes with Abbott's offerings in other medical device categories.
Becton Dickinson
BDX
Mkt Cap50.32B
Becton, Dickinson and Company competes with Abbott in the medical technology sector, offering devices, laboratory equipment, and diagnostic products.
Resmed
RMD
Mkt Cap32.94B
ResMed competes with Abbott in the health sector by providing medical devices for sleep disorders and respiratory conditions, which complements Abbott's broader medical device portfolio.

About

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Show more...
CEO
Robert Ford
Employees
115000
Country
United States
ISIN
NO0013735894
WKN
000A41YS7

Listings

XETRA
DE
ABL.XETRA
MI
IT
1ABT.MI
F
DE
ABL0.F
ST
SE
ABTO.ST

0 Comments

Share your thoughts

FAQ

What is Aqua Bio Technology ASA stock price today?▼
The current price of 0I8C.LSE is kr5.10 NOK — it has increased by +0% in the past 24 hours. Watch Aqua Bio Technology ASA stock price performance more closely on the chart.
What is Aqua Bio Technology ASA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on London Exchange exchange Aqua Bio Technology ASA stocks are traded under the ticker 0I8C.LSE.
Is Aqua Bio Technology ASA stock price growing?▼
0I8C.LSE stock has risen by +0% compared to the previous week, the month change is a +3.03% rise, over the last year Aqua Bio Technology ASA has showed a -86.07% decrease.
What is Aqua Bio Technology ASA market cap?▼
Today Aqua Bio Technology ASA has the market capitalization of 8.82B
When is the next Aqua Bio Technology ASA earnings date?▼
Aqua Bio Technology ASA is going to release the next earnings report on October 21, 2026.
What were Aqua Bio Technology ASA earnings last quarter?▼
0I8C.LSE earnings for the last quarter are 12.67 NOK per share, whereas the estimation was 12.35 NOK resulting in a +2.56% surprise. The estimated earnings for the next quarter are N/A NOK per share.
What is Aqua Bio Technology ASA revenue for the last year?▼
Aqua Bio Technology ASA revenue for the last year amounts to 449.63B NOK.
What is Aqua Bio Technology ASA net income for the last year?▼
0I8C.LSE net income for the last year is 66.08B NOK.
Does Aqua Bio Technology ASA pay dividends?▼
Yes, 0I8C.LSE dividends are paid annual. The last dividend per share was 50 NOK. As of today, Dividend Yield (FWD)% is 454.23%.
How many employees does Aqua Bio Technology ASA have?▼
As of September 10, 2026, the company has 115,000 employees.
In which sector is Aqua Bio Technology ASA located?▼
Aqua Bio Technology ASA operates in the Health & Wellness sector.
When did Aqua Bio Technology ASA complete a stock split?▼
The last stock split for Aqua Bio Technology ASA was on February 27, 2026 with a ratio of 1:50.
Where is Aqua Bio Technology ASA headquartered?▼
Aqua Bio Technology ASA is headquartered in ABBOTT PARK, United States.